NSE filing, NSE: BALAJIPHOS. Summary written from the filing by ALFA Finder's alert engine.
Balaji Phosphates Ltd: key numbers
- Share price
- ₹105.00
- Market cap
- ₹249.7 Cr
- Revenue (annual)
- ₹170.5 Cr
- Net profit (annual)
- ₹10.22 Cr
- P/E (TTM)
- 24.4×Sector 9.6×
- Promoter holding
- 69.90%
- FII holding
- 1.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balaji Phosphates Ltd
All →Balaji Phosphates Fund Raise of ₹23.45 Cr
Balaji Phosphates received shareholder approval to issue 25,00,000 convertible warrants worth ₹23.45 Crore and 14,49,900 equity shares for a business acquisition via preferential issue.
- Value
- ₹23.45 Cr
Balaji Phosphates Capital Structure Change
Balaji Phosphates' shareholders approved the issuance of 5,146,350 convertible warrants and 1,449,900 equity shares to promoters and other investors at the 30th AGM.
Balaji Phosphates Annual General Meeting
Balaji Phosphates Limited issued a corrigendum to its 30th Annual General Meeting notice. The amendment provides revisions to the proposed preferential share allotment for business acquisition.
Balaji Phosphates Board Meeting Outcome
Balaji Phosphates Limited replaced an allottee for its proposed 25 lakh warrant issuance. The board also approved a corrigendum to its AGM notice per NSE observations.
- Value
- ₹23.45 Cr
Balaji Phosphates Board Meeting Date
Balaji Phosphates Limited scheduled a board meeting for September 18, 2026, to discuss fund raising via preferential issue.
Balaji Phosphates Annual Report
Balaji Phosphates Limited has submitted its Annual Report for the financial year 2025-26, which includes the notice for its 30th Annual General Meeting.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.